$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
More People Died in the Key Clinical Trial for Pfizers COVID Vaccine than the Company Publicly Reported
07:25pm, Thursday, 18'th Nov 2021 The Centre for Research on Globalization (CRG)
All Global Research articles can be read in 51 languages by activating the Translate Website drop down menu on the top banner of our home page (Desktop version). To receive Global Researchs Daily Newsletter (selected articles), click here . Visit The post More People Died in the Key Clinical Trial for Pfizers COVID Vaccine than the Company Publicly Reported appeared first on Global Research .
Rede Wealth LLC Invests $203,000 in Pfizer Inc. (NYSE:PFE)
07:16pm, Thursday, 18'th Nov 2021 Dakota Financial News
Rede Wealth LLC acquired a new position in shares of Pfizer Inc. (NYSE:PFE) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 4,725 shares of the biopharmaceutical companys stock, valued at approximately $203,000. Other hedge funds have also modified their holdings []
Pfizer announces XELJANZ granted European approval for new indication
07:16pm, Thursday, 18'th Nov 2021 Seeking AlphaPfizers XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis
06:30pm, Thursday, 18'th Nov 2021 Business Wire
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the European Commission has approved XELJANZ® (tofacitinib) 5 mg twice daily for the treatment of adults with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapy. XELJANZ is the first and only oral Janus kinase (JAK) inhibitor approved for five indications in the European Union (EU), including in adults with moderate to severe active rheumatoid arthritis (RA), adults with active psoria
US orders 10 million courses of anti-Covid treatment pills from Pfizer
06:21pm, Thursday, 18'th Nov 2021 FRANCE 24
President Joe Biden on Thursday announced the United States is buying 10 million courses of Pfizer''s Covid-19 treatment pill, in a $5.3 billion deal he touted as "critical" to fighting the pandemic.
Pfizer, US gov sign $5 billion deal for possible COVID-19 treatment
06:16pm, Thursday, 18'th Nov 2021 New York Post
Pfizer asked the FDA on Tuesday to authorize emergency use of the experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths
Release of US vaccine data may take till 2076
06:13pm, Thursday, 18'th Nov 2021 Big News Network
The US Food and Drug Administration (FDA) may take 55 years to release all the documents it used to declare Pfizer''s Covid-19 vaccine safe, a group of doctors and professors claim. The FDA approved Pfizer/BioNTech''s Covid-19 vaccine for people aged 16 and over in August, and, last month, extended its emergency-use authorization to children as young as five. This week, FDA regulators are expected
Pfizer says B.C. floods causing delays in deliveries of COVID-19 vaccine
06:12pm, Thursday, 18'th Nov 2021 Global News Canada
The delays come on the heels of reports, confirmed by Global News, that Health Canada on Friday will give the green light to Pfizer''s COVID-19 vaccine for kids aged five-11.
Release of US vaccine data may take till 2076
06:09pm, Thursday, 18'th Nov 2021 Russia Today
The US Food and Drug Administration (FDA) may take 55 years to release all the documents it used to declare Pfizers Covid-19 vaccine safe, a group of doctors and professors claim. Read Full Article at RT.com
Global Auto-Injector Market Outlook Report 2021-2030 Featuring Pfizer, BD, Adamis Pharma, Biogen, Teva Pharma, Mylan, Antares Pharma, Sanofi, Ypsomed, & SHL Medical
06:00pm, Thursday, 18'th Nov 2021 PR Newswire
DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Global Auto Injector Market Outlook 2030" report has been added to ResearchAndMarkets.com''s offering. The market is estimated to garner a revenue of close to USD 11350 Million by the end of 2030, up from a revenue of about USD 3120 Million in the
Pfizer to Sell 10Mln Doses of Anti-Viral COVID-19 Treatment to US Government for $5.29Bln
02:48pm, Thursday, 18'th Nov 2021 UrduPointGerman Vaccination Commission Recommends Boosters for People Over 18
02:44pm, Thursday, 18'th Nov 2021 Dawn News
The German vaccination committee STIKO advises all vaccinated adults to give an extra shot with the corona vaccines from Pfizer/BioNTech or Moderna. The so-called booster shot is currently only available for the oldest residents of Germany and other risk groups. According to the committee, the booster should ensure that vaccinated persons remain well protected […] The post German Vaccination Commission Recommends Boosters for People Over 18 appeared first on Dawn News .
Cardiff Oncology Stock Rises After $15M Equity Investment From Pfizer
02:30pm, Thursday, 18'th Nov 2021 Benzinga
Pfizer Inc (NYSE: PFE ) has made a $15 million equity investment in Cardiff Oncology Inc (NASDAQ: CRDF ) as part of the Pfizer Breakthrough Growth Initiative. Pfizer purchased 2.4 million shares of Cardiff Oncology''s shares at $6.22 Full story available on Benzinga.com
DBMR has added a new report titled Anti-Infective Drugs Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. This research report is generated by thoroughly understanding
Pfizer Secures $5 Billion From US Government for 10 Million Courses of COVID-19 Pill
02:14pm, Thursday, 18'th Nov 2021 The Epoch Times
U.S. government officials have reached an agreement with Pfizer that secures 10 million courses of the drugmakers COVID-19 pill. The government is paying $5.3 billion, or $529 a course for the pill. The price is due to the high committed volume of treatment courses being purchased through 2022, with similar agreements reached with several other []
Sign In
Buy PFE